U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H9NO
Molecular Weight 135.1632
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENZENEACETAMIDE

SMILES

NC(=O)CC1=CC=CC=C1

InChI

InChIKey=LSBDFXRDZJMBSC-UHFFFAOYSA-N
InChI=1S/C8H9NO/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H2,9,10)

HIDE SMILES / InChI

Molecular Formula C8H9NO
Molecular Weight 135.1632
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
LC-MS profiling of N-alkylamides in Spilanthes acmella extract and the transmucosal behaviour of its main bio-active spilanthol.
2010-11-02
2,3-Disubstituted acrylamides as potent glucokinase activators.
2010-10-01
Structural characterization of the Hepatitis C Virus NS3 protease from genotype 3a: the basis of the genotype 1b vs. 3a inhibitor potency shift.
2010-09-30
Antitrypanosomal and antileishmanial activities of novel N-alkyl-(1-phenylsubstituted-beta-carboline)-3-carboxamides.
2010-07
Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives.
2010-04-01
The influence of leukotriene receptors' antagonists on experimentally induced ulcer in rats.
2010-03-06
Heterologous expression of leader-less pga gene in Pichia pastoris: intracellular production of prokaryotic enzyme.
2010-02-03
2-(4-Bromo-phen-yl)-N-(2-methoxy-phen-yl)acetamide.
2009-12-09
Regulation of phenylacetic acid degradation genes of Burkholderia cenocepacia K56-2.
2009-10-18
Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
2009-07-15
Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
2009-06-15
N-(3,4-Diethoxy-phen-yl)acetamide.
2009-05-20
Utility of MetaSite in improving metabolic stability of the neutral indomethacin amide derivative and selective cyclooxygenase-2 inhibitor 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-phenethyl-acetamide.
2009-05
Phenylethylamide and phenylmethylamide derivatives as new tyrosinase inhibitors.
2009-02
Novel inhibitors of the v-raf murine sarcoma viral oncogene homologue B1 (BRAF) based on a 2,6-disubstituted pyrazine scaffold.
2008-06-12
Linear and cyclic peptides from the entomopathogenic bacterium Xenorhabdus nematophilus.
2008-06
QSAR and pharmacophore analysis on amides against drug-resistant S. aureus.
2008-03-04
2,2-Dichloro-N-(2,3-dimethyl-phen-yl)acetamide.
2007-12-12
Production of enantiomerically pure (S)-beta-phenylalanine and (R)-beta-phenylalanine by penicillin G acylase from Escherichia coli in aqueous medium.
2007-12
Diastereospecific photocyclization of a isopropylbenzophenone derivative in crystals and the morphological changes.
2007-08-31
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
2007-03-01
Fluorogenic substrates for lipases, esterases, and acylases using a TIM-mechanism for signal release.
2007-02
Synthesis and receptor binding studies of 3-substituted piperazine derivatives.
2006-03
[Studies on chemical constituents of the brown alga Dictyopteris divaricata].
2006-01
Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice.
2005-08-01
Metabolism of 2-phenylethylamine to phenylacetic acid, via the intermediate phenylacetaldehyde, by freshly prepared and cryopreserved guinea pig liver slices.
2005-01-14
SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease.
2004-09-06
Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta.
2004-07-05
Mandelamide hydrolase from Pseudomonas putida: characterization of a new member of the amidase signature family.
2004-06-22
Studies on anti-Helicobacter pylori agents. Part 3: A novel, efficacious cephem derivative, FR193879.
2004-05-17
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
2004-03-11
Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
2004-01
Bhimamycin A to approximately E and bhimanone: isolation, structure elucidation and biological activity of novel quinone antibiotics from a terrestrial Streptomycete.
2003-11
Novel, potent phenethylamide inhibitors of the hepatitis C virus (HCV) NS3 protease: probing the role of P2 aryloxyprolines with hybrid structures.
2003-08-18
Design of selective peptidomimetic agonists for the human orphan receptor BRS-3.
2003-05-08
The scent of age.
2003-05-07
Phenethyl amides as novel noncovalent inhibitors of hepatitis C virus NS3/4A protease: discovery, initial SAR, and molecular modeling.
2003-01-30
Role of alphaArg145 and betaArg263 in the active site of penicillin acylase of Escherichia coli.
2002-07-01
Synthesis and antimicrobial activity of some novel 2-(p-substituted-phenyl)-5-substituted-carbonylaminobenzoxazoles.
2002-03
Synthesis and structure-activity relationships of N-(1-benzylpiperidin-4-yl)arylacetamide analogues as potent sigma1 receptor ligands.
2001-12-06
A chemostat culture as a tool for the improvement of a recombinant E. coli strain over-producing penicillin G acylase.
2001-10-05
An enzyme-labile safety catch linker for synthesis on a soluble polymeric support.
2001-03-02
Substitutions of Thr-103-Ile and Trp-138-Gly in amidase from Pseudomonas aeruginosa are responsible for altered kinetic properties and enzyme instability.
2001-03
Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.
2001
Isolation and characterization of a bacterium possessing a novel aldoxime-dehydration activity and nitrile-degrading enzymes.
1998-08
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:21:48 GMT 2025
Edited
by admin
on Mon Mar 31 21:21:48 GMT 2025
Record UNII
5R219M9TJF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BENZENEACETAMIDE
Systematic Name English
.ALPHA.-PHENYLACETAMIDE
MI  
Preferred Name English
PHENACETAMIDE
Common Name English
PHENYL-.BETA.-ACETYLAMINE
Common Name English
PHENYLACETAMIDE
Common Name English
PHENYLACETIC ACID AMIDE
Systematic Name English
BENZENEDIACETAMIDE
Systematic Name English
.ALPHA.-TOLUAMIDE
Systematic Name English
NSC-1877
Code English
.ALPHA.-TOLUIMIDIC ACID
Systematic Name English
ACETAMIDE, 2-PHENYL-
Systematic Name English
.ALPHA.-PHENYLACETAMIDE [MI]
Common Name English
2-PHENYLACETAMIDE
Systematic Name English
Code System Code Type Description
CAS
103-81-1
Created by admin on Mon Mar 31 21:21:48 GMT 2025 , Edited by admin on Mon Mar 31 21:21:48 GMT 2025
PRIMARY
EPA CompTox
DTXSID1059282
Created by admin on Mon Mar 31 21:21:48 GMT 2025 , Edited by admin on Mon Mar 31 21:21:48 GMT 2025
PRIMARY
NSC
1877
Created by admin on Mon Mar 31 21:21:48 GMT 2025 , Edited by admin on Mon Mar 31 21:21:48 GMT 2025
PRIMARY
PUBCHEM
7680
Created by admin on Mon Mar 31 21:21:48 GMT 2025 , Edited by admin on Mon Mar 31 21:21:48 GMT 2025
PRIMARY
MESH
C005293
Created by admin on Mon Mar 31 21:21:48 GMT 2025 , Edited by admin on Mon Mar 31 21:21:48 GMT 2025
PRIMARY
MERCK INDEX
m8648
Created by admin on Mon Mar 31 21:21:48 GMT 2025 , Edited by admin on Mon Mar 31 21:21:48 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
203-147-0
Created by admin on Mon Mar 31 21:21:48 GMT 2025 , Edited by admin on Mon Mar 31 21:21:48 GMT 2025
PRIMARY
FDA UNII
5R219M9TJF
Created by admin on Mon Mar 31 21:21:48 GMT 2025 , Edited by admin on Mon Mar 31 21:21:48 GMT 2025
PRIMARY
CHEBI
16562
Created by admin on Mon Mar 31 21:21:48 GMT 2025 , Edited by admin on Mon Mar 31 21:21:48 GMT 2025
PRIMARY